The most active life sciences hedge fund firm in the private markets has launched its third venture capital fund.
RA Capital raised $880 million for RA Capital Nexus Fund III, which was “significantly oversubscribed,” according to a firm announcement.
It brought in capital from existing and new investors, including a group of endowments, foundations, hospital systems, and family offices, according to the firm.
Nexus
